Nonspecific anti-inflammatories like steroids might be entirely sidelined for mild-to-moderate chronic hand eczema now that three targeted topical agents are available.
Merz Therapeutics, a business of Merz Group and a leader in the field of neurotoxins, today announced that Health Canada approved XEOMIN® (incobotulinumtoxinA) for the treatment of post-stroke lower ...
Long gone are the days spent soaking up the sun outside. Now, we’re holed up indoors as much as possible, hiding from the chilly temperatures that will soon get even worse. And if you’re ...